| CDelirium symptom ever present (Over course of study drug; N (%)) | CTime spent with delirium symptom (% of total days of study drug; median (IQR)) | ||||
---|---|---|---|---|---|---|
Delirium symptoms derived from ICDSC | Quetiapine ( n = 14) | Placebo ( n = 15) | P -value | Quetiapine ( n = 14) | Placebo ( n = 15) | CP -value |
Agitation | 6 (42.9) | 7 (46.7) | 0.83 | 0 (0 to 13) | 14 (0 to 57) | 0.17 |
Decreased level of consciousness | 8 (57.1) | 7 (46.7) | 0.72 | 3 (0 to 50) | 22 (7 to 29) | 0.24 |
Inattention | 13 (92.9) | 15 (100) | 0.29 | 47 (0 to 67) | 78 (43 to 100) | 0.03 |
Disorientation | 13 (92.9) | 12 (80) | 0.59 | 35 (0 to 55) | 52 (25 to 94) | 0.27 |
Hallucinations/delusions | 2 (14.3) | 1 (6.7) | 1.00 | 0 (0 to 17) | 28 (0 to 43) | 0.10 |
Hyperactivity | 6 (42.9) | 7 (46.7) | 0.79 | 0 (0 to 20) | 14 (0 to 57) | 0.28 |
Hypoactivity | 9 (64.3) | 9 (60.0) | 0.81 | 50 (17 to 83) | 67 (22 to 88) | 0.61 |
Inappropriate speech or mood | 7 (77.8) | 4 (16.0) | 0.24 | 15 (0 to 44) | 24 (0 to 60) | 0.98 |
Sleep/wake cycle disturbances | 9 (64.3) | 10 (71.4) | 0.82 | 58 (33 to 100) | 83 (36 to 100) | 0.69 |
Symptom fluctuation | 11 (91.7) | 14 (93.3) | 0.52 | 47(19 to 67) | 89 (33 to 100) | 0.04 |